Delivery Order SPE2DB22D1106-SPE2DB24FEKL6
Award Date 4/8/24
Potential Completion Date 4/9/24
Potential Value $38K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Eliquis 5 mg tablets. The $17,336.55 firm fixed-price contract has a completion date of July 21, 2022. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a range of pharmaceutical...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract valued at $20,866.16 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company AmerisourceBergen Corporation, for the provision of Eliquis 5 mg tablet medication. This delivery order contract is a component of a larger indefinite delivery contract (IDC) with a potential ceiling value of $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order for $1,187.55 to supply 60 tablets of Eliquis 2.5 mg. This order is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely to Amerisourcebergen Drug Corp by DLA, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to DLA...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Eliquis 5 mg tablets. The $7,295.22 contract has a completion date of February 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA, which serves as the primary vehicle for the...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order (SPE2DX15D2216/SPE2DX24F21T6) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $1,900.08 order is for Eliquis 2.5 mg tablets and does not have a set-aside designation. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $7,119.95 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the provision of Eliquis 5 mg tablets and has a performance period through March 13, 2024. AmerisourceBergen Drug Corp is the prime contractor on this order, which was not set aside under any socioeconomic programs. Additionally, AmerisourceBergen Drug Corp holds an Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply Eliquis 5 mg tablets. The contract has a potential value of $5,872.82 and a completion date of March 7, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside program. AmerisourceBergen Drug Corp also holds an indefinite...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $47,006.39 contract is for the provision of Eliquis 5 mg tablets to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 60-count tablets of the pharmaceutical drug Eliquis 2.5 mg. The $7,600.32 contract has a performance period through March 12, 2024. AmerisourceBergen Drug Corp, located in Conshohocken, Pennsylvania, is the prime contractor on this award and has an indefinite delivery...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Eliquis 5 mg tablets. The $15,265.43 firm fixed-price contract has an ultimate completion date of April 17, 2024. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEKL6Delivery Order
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $37,550.10 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product Eliquis 5 mg tablets. This delivery order was issued under an existing indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA, which serves as the primary contract vehicle for the company to provide a comprehensive range of medications and medical supplies to military treatment programs and facilities worldwide. The contract has no set-aside designation and the performance period runs through April 9, 2024.
Generated 7/8/24, 9:11 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.6k | 4/8/24 |